Zusammenfassung
Um die oftmals beschränkten Ressourcen der kardialen Diagnostik optimal zu nützen, müssen die Strategien der Zuweisung zu invasiven (Koronarangiographie) und nichtinvasiven kardiologischen Untersuchungen (Echokardiographie und Szintigraphie) verbessert werden. Bei den notwendigen Voruntersuchungen der Patienten können sensitive und spezifische Labortests zur Diagnose von akuten und chronischen Herzerkrankungen eine wichtige Rolle erlangen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams JE III, Bodor GS, Davila-Roman VG et al. (1993) Cardiac troponin I - a marker with high specifity for cardiac injury. Circulation 88: 101–106
Andersen PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD (1991) Troponin T isoform expression in humans: a comparison among normal and failing adult heart; fetal heart and adult and skeletal muscle. Circ Res 69: 1226–1233
Bhayana V, Cohoe S, Leung FY, Jablonsky G, Henderson AR (1993) Diagnostic evaluation of creatine kinase-2-mass and creatine kinase-3 and 2-isoform ratios in early diagnosis of acute myocardial infarction. Clin Chem 39: 488–495
Burlina A, Zaniotto M, Secchiero S, Rubin D, Accorsi F (1994) Troponin T as a marker of ischemic myocardial injury. Clin Biochem 27: 113–121
Choy AMJ, Darbar D, Lang CC et al. (1994) Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 72: 16–22
Davidson NC, Coutie WJ, Struthers AD (1995) N-terminal proatrial natriuretic peptide and brain natriuretic peptid are stable for up to 6 hours in whole blood in vitro. Circulation 91: 1276–1277
Drexel H, Dworzak E, Kirchmair M et al. (1983) Myoglobinemia in the very early phase of acute myocardial infarction. Am Heart J 105: 642–651
Farah CS, Reinach FC (1995) The troponin complex and regulation of muscle concentration. FASEB J 9: 755–767
Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B (1996) Natriuretic peptides and cyclic guanosine monophosphate in asysmptomatic left ventricular dysfunction. Heart 76: 129–136
Gibler WB, Young GP, Hedges JR et al. (1992) Acute myocardial infarction in chest pain patients with nonodiagnostic EGGs: Serial CK-MB sampling in the emergency department. Ann Emerg Med 21: 504–512
Hall C, Rouleau JL, Moye E et al. (1994) N-terminal proatrial natriuretic factor - an independent predictor of long term prognosis after myocardial infarction. Circulation 89: 1934–1942
Hall C, Aaberge L, Stokke O (1995) In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important perequisite for ist use as a biochemical parameter of atrial pressure in clinical routine. Circulation 91: 911
Hamm CW, Ravkilde J, Gerhart W et al. (1992) The prognositc value of serum troponin T in unstable angina. N Engl J Med 327: 146–150
Hunt PJ, Yandle TG, Nicholls MG et al. (1995) The aminoterminal portion of pro-brain natriuretic peptide ( Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214: 1175–1183
Ingwal JS, Kramer MF, Fifer M et al. (1985) The creatine kinase system in normal and diseased human myocardial. N. Engl J Med 313: 1050–1054
Jakob G, Mair J, Puschendorf B, Pichler M (1995) Ergometric exercise testing improves the sensitivity of cyclic guanosine 3′5′ monophosphate to diagnose asymptomatic left ventricular dysfunction. Br Heart J 73: 145–150
Johnstone DE, Abdulla A, Arnold JMO et al. (1994) Canadian cardiovascular societies consensus conference. Diagnosis and management of heart failure. Can J Cardiol 10: 613–631
Karrenbrock B, Heim JM, Gerzer R (1990) Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3′5′ cyclic monophosphate levels in healthy volunteers. Klin Wochenschr 68: 213–217
Katus HA, Remppis A, Neumann FJ et al. (1991) Diagnostic efficiency of Troponin T measurements in acute myocardial infarction. Circulation 83: 902–912
Katus HA, Muller-Bardorff M, Hallermayer K. (1995)The second generation of the cardiac troponin T ELISA: improved specificity. Clin Chem 41: 1201–1202
Laperche T, Steg PG, Dehoux M et al. (1995) A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. Circulation 92: 2079–2086
Lauer B, Niederau C, Kühl V, Schannwell M, Schultheiss HP (1995) Assesment of myocardial cell damage in patients with myocarditis by serum levels of cardiac troponin T. Eur Heart J 16 [Suppl 299]: 1710
Lee T, Rouan GW, Weisberg MC et al. (1987) Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 60: 219 - 224
Lerman A, Gibbons RJ, Rodeheffer RJ et al. (1993) Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 341: 1105–1109
Mair J, Artner-Dworzak E, Dienstl A et al. (1991) Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 68: 1545–1550
Mair J, Artner-Dworzak E, Lechleitner et al. (1991) Cardiac Troponin T in diagnosis of acute myocardial infarction. Clin Chem 37: 845–852
Mair J, Artner-Dworzak E, Lechleitner P et al. (1992) Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 68: 462–468
Mair J, Puschendorf B, Smidt J et al. (1994) Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alternations. Br Heart J 72: 125–127
Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B (1995) Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, cardiac troponin I and T for acute myocardial infarction. Clin Chem 41: 1266–1272
Mair J, Genser N, Morandell D et al. (1996) Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta 245: 19–28
Mair P, Mair J, Seibt I, Balogh D, Puschendorf B (1993) Early and rapid diagnosis of perioperative myocardial infarction in aortocoronary bypass surgery by immunoturbidimetric myoglobin measurements. Chest 103: 1508–1511
Mair P, Mair J, Krause EG, Balogh D, Puschendorf B, Rabitzsch G (1994) Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting. Eur J Clin Chem Clin Biochem 32: 543–547
Michael LH, Hunt JR, Weilbach D (1985) Creatine kinase and phosphorylase in cardiac lymph. Coronary occlusion and reperfusion. Am J Physiol 248: 350–359
Neumeier D, Jockers-Wretou E (1981) Tissue specific and subcellular distribution of creatine kinase isoenzymes. In: Lang H (ed) Creatine kinase isoenzymes - pathophysiology and clinical application. Springer, Berlin Heidelberg New York, pp 85–129
Nieuwenhoven FA van, Kleine AH, Wodzig WH et al. (1995) Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ration of myoglobin over fatty acid binding protein. Circulation 92: 2848–2854
Ohmann EM, Casey C, Bengston JR, Pryor D, Tomey W, Horgan J (1990) Early detection of acute myocardial infarction; additional information from serum concentrations of myoglobin in patients without ST-elevation. Br Heart J 63: 335–338
Packer M (1992) Pathophysiology of chronic heart failure. Lancet 340: 88–92
Puleo PR, Meyer D, Wathen C et al. (1994) Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331: 561–566
Ravkilde J, Nissen H, Horder M, Thygesen K (1995) Independent prognostic value of serum creatine kinase isoenzyme, MB mass, cardiac troponin T and myosin light chain levels in suspected myocardial infarction. J Am Coll Cardiol 25: 574–581
Somer H, Duboeitz V, Donner M (1976) Creatine kinase isoenzymes in neuromuscular diseases. J Neurol Sci 29: 129–136
Sylven C, Jannson E, Book K (1984) Myoglobin content in human skeletal muscle and myocardium: relation to fibre and size and oxidative capacity. Cardiovasc Res 18: 443–446
Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project-Registration procedures, event rates, and case-fatality rates 38 populations from 21 countries in four continents. Circulation 90: 583–612
Vorderwinkler KP, Artner-Dworzak E, Jakob G et al. (1991) Release of cyclic guanosine mo-nophosphate evaluated as a diagnostic tool in cardiac diseases. Clin Chem 37: 186–190
Wei CM, Heublein DM, Perrella MA et al. (1993) Natriuretic peptide system in human heart failure. Circulation 88: 1004–1009
Williams JF, Bristow MR, Fowler MB et al. (1995) ACC/AHA Task Force Report.Guidelines for the evaluation and management of heart failure. Circulation 92: 2764–2784
Yoshimura M, Yaue H, Okumura K et al. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87: 464–469
Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H (1993) Analysis of creatine kinase, CK-MB, Myoglobin, and troponin T time, activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 87: 1542–1550
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Puschendorf, B. (1998). Wertigkeit von Laborparametern für Diagnostik und Therapiekontrolle kardialer Erkrankungen. In: Unger, F. (eds) Herzerkrankungen und Interventions-möglichkeiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80404-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-80404-5_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80405-2
Online ISBN: 978-3-642-80404-5
eBook Packages: Springer Book Archive